Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Investigation of the Reliability and Validity of the Movement Imagination Questionnaire - Revised Second in Acute Stroke Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04283760
Recruitment Status : Recruiting
First Posted : February 25, 2020
Last Update Posted : February 25, 2020
Sponsor:
Information provided by (Responsible Party):
Fatma Nurveren, Hacettepe University

Brief Summary:

Our study was planned to investigate the reliability validity of the Movement Imagery Questionnaire- RS in acute stroke patients.

For our study, the Turkish version of the Movement Imagery Questionnaire-RS will be established first. Then, the reliability and validity of the questionnaire in acute stroke patients will be examined.

The study included 70 stroke patients hospitalized in the Stroke Unit of the Neurology Department of Hacettepe University Hospitals and individuals between 50-75 years of age who do not have any disease in Ankara.


Condition or disease
Acute Stroke

Detailed Description:
Motor imagery is a cognitive process that the person continues mentally without actually performing a particular motor movement. The concept of motor imaging has become more and more important in recent years and has allowed us to obtain different ideas about the emergence of motor movements. When the literature is analyzed, it was reported that the brain areas activated during the motor movement of individuals overlap with the active areas in the imaging process.As an individual's ability to imagine movement increases, the centers participating in the motor system become so activated. In the literature, it has been stated that this motor imaging ability may decrease in people who have had a stroke. For this reason, the motor imagination ability of the person should be evaluated before a suitable rehabilitation program is decided.When we look at the literature, it was seen that the Movement Imagery Questionnaire - Revised Second was used to evaluate the patients with subacute and chronic stroke, and there was no validity and reliability study in patients with acute stroke. Considering this situation, it was planned to translate the Movement Imagery Questionnaire -RS questionnaire into our language within the scope of our study and then to investigate the reliability and validity of patients with acute stroke.

Layout table for study information
Study Type : Observational
Estimated Enrollment : 70 participants
Observational Model: Other
Time Perspective: Prospective
Official Title: Investigation of the Reliability and Validity of the Movement Imagination Questionnaire - Revised Second in Acute Stroke Patients
Actual Study Start Date : September 11, 2019
Estimated Primary Completion Date : June 2020
Estimated Study Completion Date : June 2020

Group/Cohort
Healthy Group
  1. Demographic Information
  2. Mental Chronometry Test
  3. Movement Imagination Questionnaire- Revised Second
  4. Beck Depression Inventory
Acute Stroke Patients
  1. Demographic Information
  2. Mental Chronometry Test
  3. Movement Imagination Questionnaire- Revised Second
  4. Beck Depression Inventory
  5. Trail Making Test
  6. Barthel Index
  7. Motor Assessment Scale
  8. Trunk Impairment Scale
  9. Mini Mental Test
  10. Glaskow Coma Scale



Primary Outcome Measures :
  1. Movement Imagination Questionnaire - Revised Second [ Time Frame: about 15 minutes ]
    Movement Imagination Questionnaire - Revised Second is a questionnaire used to evaluate motor imaging ability. The Movement Imagination Questionnaire has been revised especially for use in patients with motor function loss such as stroke. The questionnaire has 7 activities in total. Although most of these activities are sitting, there are also activities that must be done during standing. Each action is questioned both visually and kinesthetically and is scored based on the ease of visualization in the range of 0-7 points. Higher scores mean a better outcome.


Secondary Outcome Measures :
  1. The Motor Assessment Scale [ Time Frame: about ten minutes ]
    The Motor Assessment Scale is designed to measure the functional properties of stroke patients. This assessment method evaluates the ability of stroke patients to perform functional tasks. The Motor Assessment Scale consists of eight motor tasks: (1) turning from the supine position, (2) sitting on your back, (3) sitting balance, (4) standing up, (5) walking, (6) upper limb function (7) hand gestures and (8) advanced hand gestures. In addition to these eight engines, the Motor Assessment Scale contains one more item that measures the overall tone. Each item is evaluated on a seven-degree scale from 0 to 6 (optimal motor behavior). The criterion for each degree in the scale corresponds to the description of the activity to be performed. In some cases, the maximum score (6 points) reflects the quality of performance; in others, it corresponds to performance over a period of time.

  2. Mental Chronometry Test [ Time Frame: about one minute ]
    Mental chronometry is an objective method used to evaluate motor imagery. It examines the time difference between actually making a movement and imagining the same movement. In general, in healthy individuals, the imagined movement time and movement time are related, but there are studies showing that this time is impaired in stroke patients. In our study, a 10 m walking test will be used to measure mental chronometry. First of all, the patient will be asked to walk 10 m independently and the time will be recorded. He will then be asked to imagine the movement and stop the stopwatch when he begins to imagine and stop himself again when he ends. Time difference and mental chronometry rate will be calculated.

  3. Trail Making Test [ Time Frame: about five minutes ]
    Trail Making Test It is used to evaluate individuals' visual scanning speed, managerial functions, visual-motor perception, motor function, planning, organization, abstract thinking and response limitation. The test consists of 2 parts, A and B. In section A, the individual is asked to combine the numbers from 1 to 25 and completion time is recorded. In section B, the individual completes the ordering, corresponding to a number and a letter, respectively, and the completion time is recorded.

  4. Barthel Index [ Time Frame: about 5 minutes ]
    Barthel Index evaluates the basic activities of daily life in order to determine at what level individuals can independently determine activities such as nutrition, washing, self-care, dressing, bowel care and bladder care, sitting on the toilet, going from bed to wheelchair, using walking / wheelchair and climbing stairs. It is a 10-item scale. The scale has scoring ranging from 0 to 20 or 0 to 100 depending on the daily life activities.

  5. Mental Chronometry Ratio [ Time Frame: about one minute ]
    Real performance time - imagery time/ real performance time

  6. Trunk Impairment Scale [ Time Frame: about one minute ]
    Trunk Impairment Scale is a scale that evaluates post-stroke body disorder. The scale, consisting of 7 parameters, also includes perception of vertical posture, trunk rotation muscle strength and reflexes on the affected and unaffected side, and vertical stop and abdominal manual muscle test sub parameters in Tsuji and colleagues' stroke disorder evaluation set. Each parameter is evaluated over 4 points. The total score ranges from a minimum of 0 to a maximum of 21 points. A higher score means better performance. In this study, only the vertical stop subscale of this scale will be used.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   50 Years to 75 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
The study included 70 stroke patients hospitalized in the Stroke Unit of the Neurology Department of Hacettepe University Hospitals and individuals aged 50-75 years living in Ankara who do not have any disease.
Criteria

Inclusion Criteria:

Acute Stroke Patients:

  • Ischemic stroke diagnosis by the relevant neurologist,
  • At least 24 hours after stroke,
  • Stroke for the first time
  • Stable vital signs and no improvement in symptoms for 48 hours
  • 50 to 75 years of age
  • 15 points from Glaskow Coma Scale (GCS),
  • Absence of apraxia and aphasia (apraxia and aphasia will be evaluated by the relevant neurologist.)
  • Being able to walk at least 10 m independently
  • A maximum score of 15 from the Beck Depression Inventory
  • To score 24 or more from Mini Mental Test
  • Signing the Informed Volunteer Consent Form

Healthy Group:

  • Being in the 50-75 age range
  • Signing the Informed Volunteer Consent Form
  • A maximum score of 15 from the Beck Depression Inventory
  • Not having a known neurological disease

Exclusion Criteria:

  • Supplement for stroke patients; any neurological, orthopedic, psychological (such as schizophrenia, psychosis) and systemic problems for the healthy group
  • Use of drugs to affect epilepsy, seizure attacks and cognition
  • Cerebellum or mesencephalon lesion
  • The presence of contractures or excessive spasticity in the joints to limit movement
  • Neglect of a body half
  • Irreversible visual (hemianopsia, blindness), presence of auditory disability
  • Participate in another experimental or drug study during the study

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04283760


Contacts
Layout table for location contacts
Contact: Fatma N Nurveren 5355433890 ext +90 fatmanurveren@gmail.com

Locations
Layout table for location information
Turkey
Hacettepe Üniversitesi Recruiting
Ankara, Turkey
Contact: Fatma N Nurveren    5355433890 ext 90    fatmanurveren@gmail.com   
Sponsors and Collaborators
Hacettepe University
Publications:

Layout table for additonal information
Responsible Party: Fatma Nurveren, Principal Investigator, Hacettepe University
ClinicalTrials.gov Identifier: NCT04283760    
Other Study ID Numbers: GO 19/870
First Posted: February 25, 2020    Key Record Dates
Last Update Posted: February 25, 2020
Last Verified: February 2020

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Fatma Nurveren, Hacettepe University:
acute stroke
motor imagery
visual imagery
kinesthetic imagery
Additional relevant MeSH terms:
Layout table for MeSH terms
Stroke
Cerebrovascular Disorders
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Vascular Diseases
Cardiovascular Diseases